NCT06021444View on ClinicalTrials.gov

Efficacy and Safety of DKM420 in Patients With Osteoarthritis of Knee

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

December 30, 2020

Primary Completion Date

June 1, 2023

Study Completion Date

July 18, 2023

Conditions
Osteoarthritis of Knee
Interventions
DEVICE

DKM420

A total of 3 doses will be applied at a dose of 2 mL over 3 weeks.

DEVICE

Conjuran

A total of 3 doses will be applied at a dose of 2 mL over 3 weeks.

Trial Locations (1)

Unknown

chung-Ang University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Dongkook Pharmaceutical Co., Ltd.

INDUSTRY